Observational studyImmunotherapy2024

Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study.

Pauline M Ellerbroek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.